145 related articles for article (PubMed ID: 14747434)
1. The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice.
Sinclair D; Saas M; Stevens JM
J Clin Pathol; 2004 Feb; 57(2):131-4. PubMed ID: 14747434
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
[TBL] [Abstract][Full Text] [Related]
3. Appropriateness of antineutrophil cytoplasmic antibody testing in a tertiary hospital.
Robinson PC; Steele RH
J Clin Pathol; 2009 Aug; 62(8):743-5. PubMed ID: 19638546
[TBL] [Abstract][Full Text] [Related]
4. Rational requesting or rationing testing?
Lock RJ
J Clin Pathol; 2004 Feb; 57(2):121-2. PubMed ID: 14747431
[No Abstract] [Full Text] [Related]
5. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.
McLaren JS; Stimson RH; McRorie ER; Coia JE; Luqmani RA
QJM; 2001 Nov; 94(11):615-21. PubMed ID: 11704691
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
[TBL] [Abstract][Full Text] [Related]
8. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
9. [ANCA-associated vasculitis: recent methodological advances for ANCA detection].
Csernok E
Dtsch Med Wochenschr; 2018 Apr; 143(7):499-502. PubMed ID: 29614541
[TBL] [Abstract][Full Text] [Related]
10. [Relevance assessment of requests for antineutrophil cytoplasmic antibodies detection: Retrospective study led in Bordeaux Hospital, France].
Biscay P; Ralazamahaleo M; Lazaro E; Richez C; Seneschal J; Rigothier C; Contin-Bordes C; Duffau P
Rev Med Interne; 2017 Oct; 38(10):656-662. PubMed ID: 28690094
[TBL] [Abstract][Full Text] [Related]
11. Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
Arnold DF; Timms A; Luqmani R; Misbah SA
J Clin Pathol; 2010 Aug; 63(8):678-80. PubMed ID: 20702467
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis.
Gonçalves C; Pinaffi JV; Carvalho JF; Pinna FR; Constantino GT; Voegels RL; Bueno C; Bonfá E; Viana VS
Am J Rhinol; 2007; 21(6):691-4. PubMed ID: 18201448
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of distinguishing and reporting different perinuclear ANCA (P-ANCA) immunofluorescence patterns: a prospective study.
Perel SB; Prain KM; Wilson RJ; Hogan PG; Gillis D; Wong RC
Am J Clin Pathol; 2013 Aug; 140(2):184-92. PubMed ID: 23897253
[TBL] [Abstract][Full Text] [Related]
14. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
15. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
16. Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.
Wiik A
Springer Semin Immunopathol; 2001; 23(3):217-29. PubMed ID: 11591099
[No Abstract] [Full Text] [Related]
17. Antineutrophil cytoplasm antibody: positivity and clinical correlation.
Martínez Téllez G; Torres Rives B; Rangel Velázquez S; Sánchez Rodríguez V; Ramos Ríos MA; Fuentes Smith LE
Reumatol Clin; 2015; 11(1):17-21. PubMed ID: 24913965
[TBL] [Abstract][Full Text] [Related]
18. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
19. What is the significance in routine care of c-ANCA/PR3-ANCA in the absence of systemic vasculitis? A case series.
Knight A; Ekbom A; Brandt L; Askling J
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S53-6. PubMed ID: 18799054
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
